Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14634840 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1 | |
| SCHEMBL14634838 | 1.00 | SLC5A2 (0.70) | SLC5A2SLC5A1 | |
| SCHEMBL14634839 | 0.94 | SLC5A2 (0.67) | SLC5A2SLC5A1 | |
| SCHEMBL26892301 | 0.83 | SLC5A2 (0.78) | SLC5A2SLC5A1 | |
| SCHEMBL14862842 | 0.83 | SLC5A2 (0.80) | SLC5A2SLC5A1 | |
| SCHEMBL14634764 | 0.83 | SLC5A2 (0.95) | SLC5A2SLC5A1 | |
| SCHEMBL14634761 | 0.83 | SLC5A2 (0.95) | SLC5A2SLC5A1 | |
| SCHEMBL877233 | 0.83 | SLC5A2 (0.95) | SLC5A2SLC5A1 | |
| Remogliflozin Etabonate SCHEMBL23072082 | 0.82 | SLC5A2 (1.00) | SLC5A2SLC5A1 | |
| Remogliflozin Etabonate SCHEMBL15168697 | 0.82 | SLC5A2 (1.00) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011127051-A1 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-10-13 | — | — | WO | claimed |
| WO-2011127051-A1 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-10-13 | — | — | WO | disclosed |